Generic Viagra Sale in US: Pfizer Reaches Settlement With Teva

by Thilaka Ravi on  December 18, 2013 at 7:55 AM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

A patent litigation against Teva Pharmaceuticals over the sale of a generic version of blockbuster drug Viagra in the United States, which treats erectile dysfunction, was settled Tuesday by pharmaceutical giant Pfizer.
Generic Viagra Sale in US: Pfizer Reaches Settlement With Teva
Generic Viagra Sale in US: Pfizer Reaches Settlement With Teva

The settlement means Israel-based Teva "will be allowed to launch a generic version of Viagra in the US on December 11, 2017 or earlier under certain circumstances," Pfizer said in a statement.

"Teva will pay Pfizer a royalty for a license to produce its generic version," Pfizer said.

Other terms of the agreement were confidential.

Patents for Viagra, which treats erectile dysfunction, expire in April 2020, Pfizer said.

In June 2010, Pfizer lost its patent in Brazil to exclusively sell the drug. Pfizer's patent for Viagra has also expired in Europe and Japan.

The US Food and Drug Administration has granted tentative approval for Teva's generic version of Viagra, said Teva, which is the world's biggest generic drug maker.

Source: AFP

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Erectile Dysfunction Top Ten Selling Drugs 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive